98 related articles for article (PubMed ID: 19148475)
21. PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia.
Hayes MP; Wang H; Espinal-Witter R; Douglas W; Solomon GJ; Baker SJ; Ellenson LH
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5932-5. PubMed ID: 17062663
[TBL] [Abstract][Full Text] [Related]
22. Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors.
Lin Y; Jiang X; Shen Y; Li M; Ma H; Xing M; Lu Y
Endocr Relat Cancer; 2009 Mar; 16(1):301-10. PubMed ID: 18852163
[TBL] [Abstract][Full Text] [Related]
23. mtDNA mutations in invasive cervix tumors: a retrospective analysis.
Allalunis-Turner J; Ma I; Hanson J; Pearcey RG
Cancer Lett; 2006 Nov; 243(2):193-201. PubMed ID: 16412569
[TBL] [Abstract][Full Text] [Related]
24. Mutations of the PIK3CA gene in diffuse large B cell lymphoma.
Baohua Y; Xiaoyan Z; Tiecheng Z; Tao Q; Daren S
Diagn Mol Pathol; 2008 Sep; 17(3):159-65. PubMed ID: 18382359
[TBL] [Abstract][Full Text] [Related]
25. Comparison of phosphatidylinositol-3-kinase signalling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA.
Morrow CJ; Gray A; Dive C
FEBS Lett; 2005 Sep; 579(23):5123-8. PubMed ID: 16150444
[TBL] [Abstract][Full Text] [Related]
26. [Study on DNA polymerase beta gene mutation in human cervical cancer].
Han LP; Qiao YH; Dong ZM; Shi HR; Zhao GQ; Liu D
Zhonghua Fu Chan Ke Za Zhi; 2003 Oct; 38(10):618-20. PubMed ID: 14728866
[TBL] [Abstract][Full Text] [Related]
27. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
[TBL] [Abstract][Full Text] [Related]
28. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
Berlin Grace VM
Indian J Cancer; 2009; 46(3):203-7. PubMed ID: 19574671
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of single and multiple human papillomavirus types in cervical cancer and precursor lesions in Hubei, China.
Cai HB; Ding XH; Chen CC
Oncology; 2009; 76(3):157-61. PubMed ID: 19174613
[TBL] [Abstract][Full Text] [Related]
30. PIK3CA cancer mutations display gender and tissue specificity patterns.
Benvenuti S; Frattini M; Arena S; Zanon C; Cappelletti V; Coradini D; Daidone MG; Pilotti S; Pierotti MA; Bardelli A
Hum Mutat; 2008 Feb; 29(2):284-8. PubMed ID: 18022911
[TBL] [Abstract][Full Text] [Related]
31. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
Shibata T; Kokubu A; Tsuta K; Hirohashi S
Cancer Lett; 2009 Oct; 283(2):203-11. PubMed ID: 19394761
[TBL] [Abstract][Full Text] [Related]
33. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.
Matovina M; Sabol I; Grubisić G; Gasperov NM; Grce M
Gynecol Oncol; 2009 Apr; 113(1):120-7. PubMed ID: 19157528
[TBL] [Abstract][Full Text] [Related]
34. Low rate of oral human papillomavirus (HPV) infection in women screened for cervical HPV infection in Southern Italy: A cross-sectional study of 140 immunocompetent subjects.
Termine N; Giovannelli L; Matranga D; Perino A; Panzarella V; Ammatuna P; D'Angelo M; Campisi G
J Med Virol; 2009 Aug; 81(8):1438-43. PubMed ID: 19551817
[TBL] [Abstract][Full Text] [Related]
35. Correlation of inhibitor of differentiation 1 expression to tumor progression, poor differentiation and aggressive behaviors in cervical carcinoma.
Li J; Jia H; Xie L; Wang X; He H; Lin Y; Hu L
Gynecol Oncol; 2009 Jul; 114(1):89-93. PubMed ID: 19359031
[TBL] [Abstract][Full Text] [Related]
36. Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.
Hafner C; Vogt T; Landthaler M; Müsebeck J
Br J Dermatol; 2008 Jul; 159(1):214-7. PubMed ID: 18503601
[TBL] [Abstract][Full Text] [Related]
37. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
38. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.
Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857
[TBL] [Abstract][Full Text] [Related]
39. MBL2 gene polymorphisms are correlated with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer.
Segat L; Crovella S; Comar M; Milanese M; Zanotta N; Fabris A; Trevisiol C; Rossi T; De Seta F; Campello C
Hum Immunol; 2009 Jun; 70(6):436-9. PubMed ID: 19275921
[TBL] [Abstract][Full Text] [Related]
40. NOEY2 mutations in primary breast cancers and breast hyperplasia.
Yang J; Hu A; Wang L; Li B; Chen Y; Zhao W; Xu W; Li T
Breast; 2009 Jun; 18(3):197-203. PubMed ID: 19482475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]